Evogene Ltd (EVGN) Actualités

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Evogene Reports Fourth Quarter and Full Year 2024 Financial Results

Evogene Reports Fourth Quarter and Full Year 2024 Financial Results PR Newswire REHOVOT, Israel, March 6, 2025...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Evogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5, 2025

Evogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5...

Evogene Schedules Fourth Quarter 2024 Financial Results Release

Evogene Schedules Fourth Quarter 2024 Financial Results Release PR Newswire REHOVOT, Israel, Feb. 20, 2025...

AgPlenus Announces Discovery of a New Mode of Action for Fungicides Against Wheat Disease

AgPlenus Announces Discovery of a New Mode of Action for Fungicides Against Wheat Disease PR Newswire REHOVOT...

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 424B3 - Prospectus [Rule 424(b)(3)]